HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France

Welcome Message

Welcome Message

Infection Conference

Yours Sincerely
A C Matin, B.Sc., M.Sc., Ph.D
Emeritus Professor, Stanford School of Medicine

6th Edition of World Congress on Infectious Diseases |June 24-26, 2024

Dear Conference Attendees,

It is an honor and great pleasure to welcome you to the session entitled “Infectious disease”. We are living in the era of ever-escalating crisis of bacterial resistance to antibiotics; and there is continuing need to unravel bacterial infection mechanisms. A multi-disciplinary approach linking basic, clinical and public health research is needed to address these issues, including: (1) Development of new antibiotics – there have recently been promising developments in this regard; (2) Bacteria become more resistant and virulent under microgravity of space flights -- furthermore, human immunity is compromised in microgravity – measures to counter these; (4) molecular basis of disease causation.

Welcome Message

Infectious Diseases Conference

Yours Sincerely
Stephen Hsu
Professor of Augusta University, GA
United States

6th Edition of World Congress on Infectious Diseases | Hybrid Event |June 24-26, 2024

Dear Conference Attendees,

As a member of the Organizing Committee, I would like to welcome you to participate in the 6th Edition of World Congress on Infectious Diseases – INFECTION 2024 in the lovely city of Paris, France, during June 24-16. This year’s conference will include many interesting scientific sessions such as Coronavirus Disease -19, Parasitology & Infectious Diseases, Vaccines and Vaccination, Bacterial Infection and Diseases, Viral Infectious Diseases, Fungal Infectious Diseases, and STD and HIV Infection, etc. With colleagues coming from all over the world, your participation will certainly contribute to the fight against infectious diseases worldwide.

Thank you.

Welcome Message

Infection Conferences

Yours Sincerely
Daniel A. Lichtenstein Ambroise Pare Hospital, France

6th Edition of World Congress on Infectious Diseases | June 24-26, 2024 | Hybrid Event

Dear congress visitors,

It is an honor and pleasure to write a few welcome notes. This conference deals with a wide subject of prime importance in the field I work with (critical care medicine, where sepsis is one of the major concerns). I am impressed so see so many countries involved, making this congress a really international one. Infections concern all countries regardless their income, and this conference is welcome. The topics cover a wide area, with a fine mingling between experts talks and more basic ones. In this perspective, my topic, equivalent so to speak to “how to diagnose pneumonia [using ultrasound]” may appear oversimplistic, so likely, I will learn more than teach. This is all the more true that the topics seem much more clinical than fundamental, with the advanges for the patients one can imagine.

Welcome Message

Infectious Diseases Conferences

Yours Sincerely
Krzysztof Skowron Nicolaus Copernicus University in Torun, Poland

6th Edition of World Congress on Infectious Diseases (Infection 2024) | June 24-26, 2024 | Hybrid Event

Dear Conference Attendees,

It is with great pleasure and honor that I extend a warm welcome to all of you participating in the session entitled "Antimicrobials/Antibiotics/Antibacterial". In the face of the escalating challenge posed by antimicrobial resistance, particularly the growing resistance of bacteria to antibiotics, our collective efforts are crucial to explore innovative solutions.

In recent years, the urgent need for new and effective antimicrobial agents has become apparent. This session aims to delve into the diverse spectrum of problems associated with antimicrobial resistance and present cutting-edge techniques for combatting microorganisms, not limited to traditional antibiotics. Recognizing the gravity of the situation, a multidisciplinary approach is imperative, combining the exploration of novel drugs with both basic and clinical research. The pursuit of groundbreaking interventions is essential to secure therapeutic success, especially in the context of infections caused by multidrug-resistant strains. This session provides a unique platform for participants, ranging from seasoned researchers to budding scholars, scientists, clinicians, and academics, to foster an exchange of ideas and knowledge.

Several key topics will be addressed in our session, including:

  1. Novel Antimicrobial Agents: Exploring innovative drugs and treatments beyond traditional antibiotics to tackle evolving resistance challenges.
  2. Multidisciplinary Research: Encouraging collaborative efforts in basic and clinical research to develop a comprehensive understanding of antimicrobial resistance mechanisms.
  3. Alternative Therapies: Delving into non-antibiotic approaches for combating pathogenic microorganisms and their potential applications in clinical settings.
  4. Global Perspectives on Antimicrobial Resistance: Discussing the varying degrees of antimicrobial resistance across regions and exploring strategies for global collaboration.
  5. Clinical Implications and Challenges: Examining the practical implications of antimicrobial resistance in clinical settings and addressing the challenges faced by healthcare professionals.

Our conference serves as a unique opportunity for all participants to not only gain insights into the latest research on antimicrobial drugs but also to engage in meaningful discussions that can shape the future of antimicrobial therapies.

Welcome Message

Infectious Diseases Conference

Yours Sincerely
Masafumi Seki MD, PhD. Professor, Saitama Medical University International Medical Center, Japan

6th Edition of World Congress on Infectious Diseases | June 24-26, 2024 | Paris, France | Hybrid Event

Dear Colleagues and Friends,

It is our great pleasure to invite distinguished researchers to the Infection 2024 on June 24-26, 2024 at Paris, France. Science about infectious diseases field today makes unprecedented progress since the pandemics of novel influenza 2009 and COVID-19. This opens new opportunities to adapt new era to social change, to achieve higher treatment and prevention efficiency, and to introduce intelligent, differentiated methods to works against these infectious diseases. It is obvious that both basic and clinical research could go together, and these studies based of precise microbiological and clinical evidence will be the future basis for success.